---
module: 020-02
language: en
chapter: 20
title: "Acute Kidney Injury, Chronic Kidney Disease, and Renal Pharmacology"
module_title: "Kidney injury phenotypes, recovery trajectories, and replacement decisions"
source_sha256: 730abd69efc1ba2f4e35d336761b4cac2ac3298e57aa5a4f6f210bd448031b09
---
# Kidney injury phenotypes, recovery, and replacement decisions

## Injury as a syndrome
### Loss of filtration or urine, not one lesion
### Haemodynamic, tubular, interstitial, glomerular, vascular, obstructive
### Pre-renal label suggests intact responsive tissue
#### Prolonged stress becomes structural injury
#### Tubular injury keeps reversible haemodynamic components
### Assess perfusion, congestion, exposure, sediment, trajectory
### Oliguria is earlier evidence but confounded

## Haemodynamic and congestive phenotypes
### Reduced filling activates sympathetic and hormonal responses
#### Restoring pressure can reverse it before injury
### Congestion lowers the filtration gradient
#### Impaired lymphatic drainage and sodium retention
#### Repeated fluid for a rising creatinine worsens it
### Abdominal and airway pressure alter renal venous return

## Tubular injury and repair
### Lost polarity, redistributed transporters, obstructed lumens
### Back-leak, inflammation, vasoconstriction sustain low filtration
### Surviving cells dedifferentiate, migrate, proliferate
#### Polyuric phase precedes restored concentrating capacity
### Maladaptive repair causes capillary loss and fibrosis
#### Biochemical recovery can hide reduced reserve
### Pigment injury: toxicity, obstruction, vasoconstriction
#### Potassium and calcium hazards precede creatinine

## Interstitial, glomerular, and vascular urgency
### Interstitial nephritis often lacks the classic triad
### Active sediment raises glomerular urgency
#### Delay converts inflammation into crescents and scar
### Thrombotic microangiopathy: endothelium, platelets, haemolysis
#### Selected mechanisms need time-critical specific treatment
### Vascular disease can give a bland urine

## Obstruction and decompression
### Continuing urine does not exclude obstruction
### Early blockage shows little hydronephrosis
### Chronic dilation persists without active pressure
### Decompression causes haematuria and diuresis
#### Replace a proportion, not every millilitre

## Chronic progression and risk
### Filtration category and albuminuria are two dimensions
#### Albumin predicts cardiovascular events
#### Rate of change is the third dimension
### Hyperfiltration raises single-nephron pressure
#### Filtered protein activates inflammation and fibrosis
### Blockade and cotransporter inhibition lower glomerular load
#### Early filtration dip, better long-term trajectory
### Atypical patterns should not end investigation

## Dialysis and the decision to start
### Diffusion for solute, transmembrane pressure for water
### Clearance rises with flows, membrane, and time
### Rapid urea fall can swell the brain
### Continuous therapy trades speed for steady control
#### Clotting and interruption reduce delivered dose
### Peritoneal dialysis uses capillaries and glucose gradient
#### Cloudy effluent needs urgent sampling
### Start on refractory physiology, not creatinine
#### Potassium, acidity, volume, uraemic effects, toxin
#### Modality fits stability, urgency, access, plan

## Planning before replacement
### Preparation does not begin just before dialysis
### Share progression rate and replacement possibility
### Transplantation, home therapy, in-centre dialysis, conservative care
### Explained against values and daily life
### Access, vaccination, anaemia and bone-mineral care
### Nutrition, medication education, symptom relief
### Frailty: travel burden, function, home life, carers

## Kidney biopsy
### Will the result change treatment and prognosis
### Bleeding risk, kidney size, blood pressure
### Anticoagulation, platelet count, alternative diagnoses
### A small sample can miss patchy disease
### Chronic scarring mixes with active lesions
### Allocate to light, immunological, electron microscopy
### Give the pathologist timeline and urine findings

## Prescribing and transitions
### Separate loading from maintenance dosing
### Critical illness and circuits change distribution
### Secretion inhibitors raise creatinine without injury
### Haemodynamic fall can still protect long term
### True toxicity hits tubules, interstitium, vessels, crystals
### Staged reintroduction after acute injury
### Final plan states mechanism, trajectory, monitoring
